On April 24, 2019 Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, reported that Jeff Goater, chief executive officer, will be participating and presenting a corporate update at the Solebury Trout Class of 2018 Biotech IPOs Investor Day, hosted together with Davis Polk and BMO Capital Markets (Press release, Surface Oncology, APR 24, 2019, View Source [SID1234535375]). The company will be closing the NASDAQ market as part of the conference on Thursday, April 25th.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation details:
Event: Solebury Trout Class of 2018 Biotech IPOs Investor Day
Date:Friday, April 26th
Time:9:30 AM ET
Location: Davis Polk Offices, New York, NY
A live and archived webcast of the presentation can be accessed by visiting the Investors page of the website at View Source